Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
What about Amazon?
What price did you get in first and second tranch?
Imagine all this that you have said is correct
But you can’t deny that yesterday at launch without advertising etc they have the biggest chance to have stock ready as newspapers word by mouth ohhh look new test new test but no stock
Such a shame for this missed opportunity which would have cost them nothing!
No wonder share prices is down market didn’t like it
So didnt we
😂
Let’s see what tomorrow brings :)
I always use the London stock exchange website
As this is more accurate than Google
https://www.londonstockexchange.com/stock/ABDX/abingdon-health-plc/company-page
Shows we finished 14p at end of play.
Trader90
Exactly my thoughts
How can you launch and not have stock?
It’s like saying look look look here I’ve got this and this and then not have it 🙄
I was very optimistic and still am but it’s defo a missed opportunity
When shouting from the rooftops back it up let people order have stock etc
Launch didn’t and doesn’t mean anything if you can’t buy
They have missed a trick and free marketing advertisement wasted
They still on to something as it’s still a new interesting exciting product but these things matter
The old saying is so true right
Buy the rumours sell the news! Today was one of those days
When they launched and told us who is stocking ie Superdrug
Surely it would have been better to have stock ready so as they announce and people hear it for the first time
Ohhhhhhh look first saliva pregnancy test ohhh you can’t buy
You’ve missed or wasted a opportunity no?
Am I looking it at a different way ?
Static for now considering the great news
Everyone’s thoughts?
I feel it’s going to make a move later on today
It's also worth remembering that ABDX's founder and Chairman sold his last business, Cozart, to Concateno for £64.4mm in cash. i.e. We have a strong and experienced management team at ABDX. In our sector big bucks are paid to acquire smaller rivals. You only have to look at the sale in 2021 of Wales based diagnostics and life sciences business BBI, which was sold for £400 million (x26 of our current mcap). Remember, we IPO'd 18 months ago at £100m (x 7 of our current mcap). The testing industry is growing exponentially in the UK and worldwide. The IPO enabled investment in the business and ABDX is on the launch pad ready to produce hundreds of millions of various tests. It is clear that there are lots of positive reasons to invest in ABDX moving forward. Salistick, the UK's first ever saliva-based pregnancy test is just one of many opportunities for ABDX to carve out market share. We should be back up to the placing price of 25p a share soon but in 18-24 months ABDX could be back at its ipo price of 96p a share if things start to pan out as many of us expect....
Good luck, Brighty
I hope they do go all out on promoting it :)
Already indicated to be a good sign is that
With the poll that they did it said 68% would prefer the saliva test over the original
I think the biggest part which will determine its sales volume etc
Is that will the saliva test be more convenient and welcomed by women
If that is a big yes then will it be justified for them to pay more for the saliva one
If that’s a big yes then we are on to a winner but I don’t expect it to be smooth easy and just plain selling
It’s a new product and we shall see how the consumers react
We on the move let’s see how we finish
As you said more buys coming in so looking awesome
Thanks for sharing much 165
I feel like as it’s going to be a brand new product
They really need to think it thru which route will give the best possible outcome
In terms of sale , popularity and exposure.
I too hope the afternoon shows strength and possibly breaking the 15p
We shall see
There’s always advantages and disadvantages to exclusivity deals
Based on production commitment profit margins etc I just hope abdx make the right move and really do promote it heavily.
Because it’s a new product altogether from the previous old one, you need to promote to let people know and comfort them that the change in habit of testing is actually for the better.
I know a lot of ifs
Again if there is a exclusivity deal with popular brand I feel that’s more of a good strategic move before promotion providing the key to building a distinct value proposition for targeted customers.
We could easily be entering the promotion side of things this weekend
And then Monday rns
Either way we getting closer and closer :)
Hope volume picks up today to indicate something
I thought it was last week
Then I was told to believe this week
But in reality based on the info from Abingdon themselves which can’t cause any opinions on which week etc
Is that they said by end of q2
Which means by end of this month
So we still have 2 weeks left before we can officially raise the question as to why launch has not happen
Am I making sense? 😝
Internal research suggests that 68% of consumers would prefer a saliva test over the urine standard.
Key point to show our product that is soon to be launched has a customer demand
Supply on demand :)
I hope it ease , convenience, (price) not sure yet how it compares all indicated to a positive overall experience for users